3-BROMOIMIDAZO[1,2-B]PYRIDAZINE

CAS No.
18087-73-5
CCD No.
CCD00787927
Formula
C6 H4 Br N3
MolWeight
198.023

Company information Contact Business Type Country/Region Inquiry

Capot Chemical Co.,Ltd

3-BROMOIMIDAZO[1,2-B]PYRIDAZINE

+86 (0)571-855 867 18

https://www.capotchem.com

Manufacturer
China Product inquiry 3-BROMOIMIDAZO[1,2-B]PYRIDAZINE on chemcd. Inquiry

Hangzhou MolCore BioPharmatech Co.,Ltd.

18087-73-5, 3-Bromoimidazo[1,2-b]pyridazine

+86 0571-8102 5280

https://www.molcore.com/

Lab/Research institutions
China Inquiry

Nanjing Chico Pharmaceutical Co., Ltd.

18087-73-5, 3-Bromoimidazo[1,2-b]pyridazine

86-025-84351676

http://www.chicopharm.com

Lab/Research institutions
China Product inquiry 18087-73-5, 3-Bromoimidazo[1,2-b]pyridazine on chemcd. Inquiry

Synblock,Inc.

3-BROMOIMIDAZO[1,2-B]PYRIDAZINE

+1-514-572-9596

http://www.synblock.com

Lab/Research institutions
Canada Inquiry

APEXESCHEM

18087-73-5, 3-Bromoimidazo[1,2-b]pyridazine

+86-051985618393

http://www.apexeschem.com

Lab/Research institutions
China Product inquiry 18087-73-5, 3-Bromoimidazo[1,2-b]pyridazine on chemcd. Inquiry

Shanghai Jovan Biochemical Technology Co., Ltd.

18087-73-5, 3-BroMoiMidazo[1,2-b]pyridazine

86-21-61654350

http://www.jovan-biochem.com/

Lab/Research institutions
China Product inquiry 18087-73-5, 3-BroMoiMidazo[1,2-b]pyridazine on chemcd. Inquiry

labseeker co.,ltd

3-BROMOIMIDAZO[1,2-B]PYRIDAZINE

86-512-63008636

http://www.labseeker.com

Lab/Research institutions
China Inquiry

ShangHai ChangYan Chem & Tech CO.,LTD

3-BROMOIMIDAZO[1,2-B]PYRIDAZINE

021-20242659

http://www.changyanchem.com

Lab/Research institutions
China Inquiry

Tetrahedron Scientific Inc

3-BROMOIMIDAZO[1,2-B]PYRIDAZINE

86 (0)571-8848 9473

http://www.thsci.com

Lab/Research institutions
China Inquiry

Bide Pharmatech Ltd

18087-73-5, 3-Bromoimidazo[1,2-b]pyridazine

+86 21 61629020

http://www.bidepharmatech.com/

Trading Company
China Inquiry

* If the product has intellectual property rights, a license granted is must or contact us.